Childhood cancer survivors--living beyond cure

P Kurkure1, S Achrekar, N Dalvi

  • 1Department of Medical and Pediatric Oncology, Tata Memorial Hospital, Mumbai, India. kurkure@vsnl.com

Insights

Pediatric cancer survivors face significant long-term health challenges, with an estimated 50% developing disabilities. Addressing these late morbidities is crucial for ensuring survivors achieve a quality of life comparable to their peers.

Area of Science:

  • Pediatric Oncology
  • Cancer Survivorship Research
  • Long-term Health Outcomes

Background:

  • Improved treatments have increased survival rates for pediatric malignancies.
  • The concept of a
  • cured child
  • now includes physical, mental, and emotional well-being alongside disease eradication.
  • Delayed consequences of cancer therapies pose a significant long-term risk to survivors' quality of life.

Purpose of the Study:

  • To highlight the growing concern of late morbidity in pediatric cancer survivors.
  • To emphasize the importance of addressing long-term health issues beyond acute treatment complications.
  • To underscore the potential impact of treatment-related disabilities on survivors' lives.

Main Methods:

  • This abstract is based on a review of existing data and estimations regarding pediatric cancer survivorship.
  • It synthesizes information on survival rates, treatment advancements, and projected survivor populations.
  • The focus is on the anticipated long-term health consequences.

Main Results:

  • The prevalence of childhood cancer survivors is increasing significantly.
  • It is estimated that 50% of pediatric cancer survivors will experience disabilities affecting their quality of life.
  • Late morbidities are a growing concern in this population.

Conclusions:

  • While increased survival is a medical triumph, the long-term health of pediatric cancer survivors requires urgent attention.
  • Addressing delayed consequences of therapy is essential for achieving a true
  • cured child
  • 's
  • holistic well-being.
  • Further research and supportive care strategies are needed to mitigate long-term morbidities and improve survivors' quality of life.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.